…erapy arm, cohorts of patients with locally advanced/metastatic solid tumours received once-weekly W0180 at increasing doses (from 3.5 to 600…
Solid Tumours
This disease is selected. Its supporting articles are shown below.
Articles mentioning Solid Tumours
25 articles · page 1 of 3… pan-cytokeratin; PSGL1, P-selectin glycoprotein ligand-1; SCC, squamous cell carcinoma; SD, stable disease; VISTA, V domain-containing immunoglobulin …
…buting to the development of more effective immunotherapies for solid tumours.This work was supported by the European Research Council (ERC) …
…dult subjects with histologically confirmed relapsed/refractory solid tumors for which no standard treatment options are available, specific…
…Background Malnutrition is common in patients with cancer. Limited data exist on the association between nutritional stat…
…(anti-PD-1) inhibitors has revolutionised the treatment of many solid tumours, however, only 30–40% of patients will have a lasting clinical …
…TILs) has shown remarkable and durable anti-tumour responses in metastatic melanoma, even in patients unresponsive to immune checkpoint inhibitors.…
…c setting and 27.3% in second-line or later lines of treatment. Lung cancer (29.6%) and breast cancer (24.4%) were the most frequently stud…
… has emerged as a promising adoptive cell transfer strategy for solid tumours. The recent accelerated approval of lifileucel by the Food and …
…ubstances. Solid tumours accounted for 63.3% of approvals, with lung cancer achieving top ranking with 22.3%. Approvals rose from 6 in 2001…
…ghlight seven previously unreported gene fusions across diverse solid tumours using RNA-based anchored multiplex polymerase chain reaction (P…
…t regimens targeting immune checkpoint inhibitors, including in hepatocellular carcinoma (HCC).1 Genetic and epigenetic intratumour heterogeneity, as we…